Biomarkers for primary biliary cholangitis: current perspectives

References

• BoonstraKBeuersUPonsioenCYEpidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic reviewJ Hepatol20125651181118822245904
   PubMed Web of Science ®Google Scholar
• KoulentakiMMantakaASifaki-PistollaDThalassinosETzanakisNKouroumalisEGeoepidemiology and space-time analysis of primary biliary cirrhosis in Crete, GreeceLiver Int2014347e200e20724502439
   PubMed Web of Science ®Google Scholar
• LindorKDGershwinMEPouponRKaplanMBergasaNVHeathcoteEJPrimary biliary cirrhosisHepatology200950129130819554543
   PubMed Web of Science ®Google Scholar
• AchenzaMIMedaFBrunettaESelmiCSerum autoantibodies for the diagnosis and management of autoimmune liver diseasesExpert Rev Gastroenterol Hepatol20126671772923237257
   PubMed Web of Science ®Google Scholar
• YamagiwaSKamimuraHTakamuraMAoyagiYAutoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significanceWorld J Gastroenterol201420102606261224627596
   PubMed Web of Science ®Google Scholar
• BensonGDKikuchiKMiyakawaHTanakaAWatnikMRGershwinMESerial analysis of antimitochondrial antibody in patients with primary biliary cirrhosisClin Dev Immunol200411212913315330448
   PubMedGoogle Scholar
• CareyEJAliAHLindorKDPrimary biliary cirrhosisLancet2015386100031565157526364546
   PubMed Web of Science ®Google Scholar
• WangJBudamaguntaMSVossJCAntimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complexJ Immunol201319152126213323894195
   PubMed Web of Science ®Google Scholar
• HuaSZhaoaFWangQChenWXThe accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysisClin Chem Lab Med201452111533154224501161
   PubMed Web of Science ®Google Scholar
• HanEJoaSJLeeHClinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosisClin Chim Acta201746411311727864100
   PubMed Web of Science ®Google Scholar
• LuCHouXLiMDetection of AMA-M2 in human saliva: potentials in diagnosis and monitoring of primary biliary cholangitisSci Rep20177179628400582
   PubMed Web of Science ®Google Scholar
• GabetaSNormanGLLiaskosCDiagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosisJ Clin Immunol200727437838717514501
   PubMed Web of Science ®Google Scholar
• OerteltSRiegerRSelmiCA sensitive bead assay for anti-mitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosisHepatology200745365966517326160
   PubMed Web of Science ®Google Scholar
• LeungPSCChoiJYangGWooEKennyTPGershwinMEA contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitisExpert Rev Mol Diagn201616669770526953925
   PubMed Web of Science ®Google Scholar
• MuratoriPMuratoriLFerrariRCharacterization and clinical impact of antinuclear antibodies in primary biliary cirrhosisAm J Gastroenterol200398243143712591064
   PubMed Web of Science ®Google Scholar
• Duarte-ReyCBogdanosDYangCYPrimary biliary cirrhosis and the nuclear pore complexAutoimmun Rev2012111289890222487189
   PubMed Web of Science ®Google Scholar
• GranitoAMuratoriPQuarnetiCPappasGCicolaRMuratoriLAntinuclear antibodies as ancillary markers in primary biliary cirrhosisExpert Rev Mol Diagn2012121657422133120
   PubMed Web of Science ®Google Scholar
• BogdanosDPLiaskosCParesAAnti-gp210 antibody mirrors disease severity in primary biliary cirrhosisHepatology20074561583 author reply 1583–158417538935
   PubMed Web of Science ®Google Scholar
• SfakianakiOKoulentakiMTzardiMPeri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patientsWorld J Gastroenterol201016394938494320954280
   PubMed Web of Science ®Google Scholar
• NakamuraMKondoHMoriTAnti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosisHepatology200745111812717187436
   PubMed Web of Science ®Google Scholar
• HuSLZhaoFRHuQChenWXMeta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosisPLoS One201497e10191625010534
   PubMed Web of Science ®Google Scholar
• BizzaroNCoviniGRosinaFOvercoming a “probable” diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literatureClin Rev Allerg Immunol2012423288297
   PubMed Web of Science ®Google Scholar
• Wesierska-GadekJKlimaAKominaORanftlerCInvernizziPPennerECharacterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodiesAnn N Y Acad Sci2007110951953017785341
   PubMed Web of Science ®Google Scholar
• MytilinaiouMGMeyerWScheperTDiagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosisClin Chim Acta201241315–161211121622503841
   PubMed Web of Science ®Google Scholar
• GranitoAYangWHMuratoriLPML nuclear body component sp140 is a novel autoantigen in primary biliary cirrhosisAm J Gastroenterol2010105112513119861957
   PubMed Web of Science ®Google Scholar
• VillaltaDSorrentinoMCGirolamiEStudy Group on Autoimmune Diseases of the Italian Society of Laboratory MedicineAutoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assayClin Chim Acta201543813513825172039
   PubMed Web of Science ®Google Scholar
• LiYZHuCJLengXMZhaoGFLiNXuYPromising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MSAnat Rec (Hoboken)2009292345546019248174
   PubMedGoogle Scholar
• HuCJSongGHuangWIdentification of new autoantigens for primary biliary cirrhosis using human proteome microarraysMol Cell Proteomics201211966968022647870
   PubMed Web of Science ®Google Scholar
• NormanGLYangCYOstendorffHPAnti-Kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosisLiver Int201535264265125243383
   PubMed Web of Science ®Google Scholar
• de LisoFMatinatoCRonchiMMaiavaccaRThe diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literatureClin Chem Lab Med2017561253128731850
   PubMed Web of Science ®Google Scholar
• BellLNWulffJComerfordMVuppalanchiRChalasaniNSerum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitisLiver Int201535126327425181933
   PubMed Web of Science ®Google Scholar
• TangYMWangJPBaoWMUrine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosisInt J Mol Med201536237738526046127
   PubMed Web of Science ®Google Scholar
• LianJSLiuWHaoSRA serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitisHepatobiliary Pancreat Dis Int201514413421
   Web of Science ®Google Scholar
• HaoJYangTZhouYSerum metabolomics analysis reveals a distinct metabolic profile of patients with primary biliary cholangitisSci Rep20177178428400566
   PubMed Web of Science ®Google Scholar
• AmathieuRTribaMNGoossensCNuclear magnetic resonance based metabolomics and liver diseases: recent advances and future clinical applicationsWorld J Gastroenterol201622141742626755887
   PubMed Web of Science ®Google Scholar
• YuMZhuYCongQWuCMetabonomics research progress on liver diseasesCan J Gastroenterol Hepatol20172017846719228321390
   PubMed Web of Science ®Google Scholar
• PisarelloMJLoarcaLIvanicsTMortonLLaRussoNMicroRNAs in the cholangiopathies: pathogenesis, diagnosis, and treatmentJ Clin Med2015491688171226343736
   PubMed Web of Science ®Google Scholar
• PadgettKALanRYLeungPCPrimary biliary cirrhosis is associated with altered hepatic microRNA expressionJ Autoimmun2009323–424625319345069
   PubMed Web of Science ®Google Scholar
• QinBHuangFLiangYYangZZhongRAnalysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosisJ Gastroenterol Hepatol201328354355023173724
   PubMed Web of Science ®Google Scholar
• QianCChenSXRenCLZhongRQDengAMQinQAbnormal expression of miR-let-7b in primary biliary cirrhosis and its clinical significanceZhonghua Gan Zang Bing Za Zhi201321753353624074714
   PubMedGoogle Scholar
• NinomiyaMKondoYFunayamaRDistinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505–3p and miR197–3p as novel biomarkersPLoS One201386e6608623776611
   PubMed Web of Science ®Google Scholar
• KatsumiTNinomiyaMNishinaTMiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitisLab Invest201696111165117727668889
   PubMed Web of Science ®Google Scholar
• TanYPanTYeYSerum microRNAs as potential biomarkers of primary biliary cirrhosisPLoS One2014910e11142425347847
   PubMed Web of Science ®Google Scholar
• LiangDYHouYQLuoLJAoLAltered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosisInt J Mol Med201638113113827246196
   PubMed Web of Science ®Google Scholar
• YangCYMaXTsuneyamaKIL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapyHepatology20145951944195324375552
   PubMed Web of Science ®Google Scholar
• QianCJiangTZhangWIncreased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosisCytokine201364117218023910013
   PubMed Web of Science ®Google Scholar
• BanalesJMSaezEUrizMUp-regulation of microRNA 506 leads to decreased Cl-/HCO3 – anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosisHepatology201256268769722383162
   PubMed Web of Science ®Google Scholar
• AnanthanarayananMBanalesJMGuerraMTPosttranslational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506J Biol Chem2015290118419625378392
   PubMed Web of Science ®Google Scholar
• EriceOMunoz-GarridoPVaqueroJMicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activationHepatology201767414201440
   Web of Science ®Google Scholar
• NakagawaRMuroyamaRSaekiCmiR-425 regulates inflammatory cytokine production in CD4+ T cells via N-Ras upregulation in primary biliary cholangitisJ Hepatol20176661223123028192189
   PubMed Web of Science ®Google Scholar
• WangXWenXZhouJMicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patientsPLoS One2017129e018429228886078
   PubMed Web of Science ®Google Scholar
• LiLMasicaDIshidaMHuman bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosisHepatology201460389690724497320
   PubMed Web of Science ®Google Scholar
• TomiyamaTYangGXZhaoMThe modulation of co stimulatory molecules by circulating exosomes in primary biliary cirrhosisCell Mol Immunol201714327628426388238
   PubMed Web of Science ®Google Scholar
• Esparza-BaquerALabianoIBujandaLPerugorriaMJBanalesJMMicroRNAs in cholangiopathies: potential diagnostic and therapeutic toolsClin Res Hepatol Gastroenterol2016401152726774196
   PubMed Web of Science ®Google Scholar
• KennedyIFrancisHMengFGlaserSAlpiniGDiagnostic and therapeutic potentials of microRNAs in cholangiopathiesLiver Res201711344129085701
   PubMedGoogle Scholar
• OlaizolaPLee-LawPYArbelaizAMicroRNAs and extracellular vesicles in cholangiopathiesBiochim Biophys Acta201818644 pt B1293130728711597
   PubMed Web of Science ®Google Scholar
• KleinRPointnerHZillyWAntimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 yearsLiver19971731191289249725
   PubMedGoogle Scholar
• VleggaarFPvan BuurenHRNo prognostic significance of anti-mitochondrial antibody profile testing in primary biliary cirrhosisHepatogastroenterology2004515893794015239218
   PubMedGoogle Scholar
• RigopoulouEIDaviesETBogdanosDPAntimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosisLiver Int20072791226123117919234
   PubMed Web of Science ®Google Scholar
• Wesierska-GadekJPennerEBattezzatiPMCorrelation of initial autoantibody profile and clinical outcome in primary biliary cirrhosisHepatology20064351135114416628641
   PubMed Web of Science ®Google Scholar
• NakamuraMShimizu-YoshidaYTakiiYAntibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosisJ Hepatol200542338639215710222
   PubMed Web of Science ®Google Scholar
• MandaiSKandaEAraiYAnti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosisClin Exp Nephrol201317340541023268283
   PubMed Web of Science ®Google Scholar
• LiberalRGrantCRSakkasLBizzaroNBogdanosDPDiagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosisClin Res Hepatol Gastroenterol201337657258523876351
   PubMed Web of Science ®Google Scholar
• MiyachiKHankinsRWMatsushimaHProfile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter studyJ Autoimmun200320324725412753810
   PubMed Web of Science ®Google Scholar
• TanaMMShumsZMiloJThe significance of autoantibody changes over time in primary biliary cirrhosisAm J Clin Pathol2015144460160626386081
   PubMed Web of Science ®Google Scholar
• MollRDivoMLangbeinLThe human keratins: biology and pathologyHistochem Cell Biol2008129670573318461349
   PubMed Web of Science ®Google Scholar
• TaoGZLiDHZhouQMonitoring of epithelial cell caspase activation via detection of durable keratin fragment formationJ Pathol2008215216417418393369
   PubMed Web of Science ®Google Scholar
• DenkGOmaryAJReiterFPSoluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseasesHepatol Res201444131286129824451045
   PubMed Web of Science ®Google Scholar
• SekiguchiTUmemuraTFujimoriNSerum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosisPLoS One2015106e013165826110613
   PubMed Web of Science ®Google Scholar
• MiyachiKHosakaHNakamuraNAnti-p97/VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?Scand J Immunol200663537638216640662
   PubMed Web of Science ®Google Scholar
• WunschEKrawczykMMilkiewiczMSerum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseasesSci Rep201663084727506882
   PubMed Web of Science ®Google Scholar
• WunschEMilkiewiczMWasikUExpression of hepatic fibroblast growth factor 19 is enhanced in primary biliary cirrhosis and correlates with severity of the diseaseSci Rep201551346226293907
   PubMed Web of Science ®Google Scholar
• ZhaoPLiuWWLiJFPredictors of liver failure in primary biliary cirrhosisUps J Med Sci20151201475125430562
   PubMed Web of Science ®Google Scholar
• HaradaKKakudaYNakamuraMShimodaSNakanumaYClinicopathological significance of serum fractalkine in primary biliary cirrhosisDig Dis Sci201358103037304323765258
   PubMed Web of Science ®Google Scholar
• NormanGLGatselisNKShumsZCartilage oligomeric matrix protein: a novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinomaWorld J Hepatol20157141875188326207169
   PubMedGoogle Scholar
• DengCHuCWangLSerological comparative proteomics analysis of mitochondrial autoantibody-negative and -positive primary biliary cirrhosisElectrophoresis2015361588159525875855
   PubMed Web of Science ®Google Scholar
• UmemuraTJoshitaSSekiguchiTSerum Wisteria floribunda agglutinin-positive Mac-2-binding protein level predicts liver fibrosis and prognosis in primary biliary cirrhosisAm J Gastroenterol2015110685786425916223
   PubMed Web of Science ®Google Scholar
• TrivediPJBrunsTCheungAOptimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid responseJ Hepatol20146061249125824548531
   PubMed Web of Science ®Google Scholar
• JoshitaSUmemuraTOtaMTanakaEAST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosisJ Hepatol20146161443144525152209
   PubMed Web of Science ®Google Scholar
• CheungKSSetoWKFungJLaiCLYuenMFPrognostic factors for transplant-free survival and validation of prognostic models in Chinese patients with primary biliary cholangitis receiving ursodeoxycholic acidClin Transl Gastroenterol201786e10028640288
   PubMed Web of Science ®Google Scholar
• WeinmannASattlerTUnoldHPPredictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patientsJ Clin Gastroenterol201549543844725014239
   PubMed Web of Science ®Google Scholar
• AliAHSinakosESilveiraMGJorgensenRAAnguloPLindorKDVarices in early histological stage primary biliary cirrhosisJ Clin Gastroenterol2011457e66e7120856137
   PubMed Web of Science ®Google Scholar
• VoumvourakiAKoulentakiMNotasGSfakianakiOKouroumalisESerum surrogate markers of liver fibrosis in primary biliary cirrhosisEur J Intern Med2011221778321238899
   PubMed Web of Science ®Google Scholar
• ZhangHCHuRFZhuTTongLZhangQQPrimary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicatorsWorld J Gastroenterol201622225276528427298571
   PubMed Web of Science ®Google Scholar
• TahtaciMYurekliOTBolatADIncreased mean platelet volume is related to histologic severity of primary biliary cirrhosisEur J Gastroenterol Hepatol201527121382138526308712
   PubMed Web of Science ®Google Scholar
• NishikawaHEnomotoHIwataYImpact of serum Wisteria floribunda agglutinin positive Mac-2-binding protein and serum interferon-c-inducible protein-10 in primary biliary cirrhosisHepatol Res201646657558326418076
   PubMed Web of Science ®Google Scholar
• HagaYKandaTSasakiRNakamuraMTakahashiKWuSSerum Wisteria floribunda agglutinin-positive Mac-2 binding protein could not always predict early cirrhosis in non-viral liver diseasesDiseases201644E3828933417
   PubMedGoogle Scholar
• ShirabeKBekkiYGantumurDMac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosisJ Gastroenterol Epub201819
   Web of Science ®Google Scholar
• DengHQiXGuoXDiagnostic accuracy of APRI, AAR, FIB-4, FI, king, Lok, Forns, and FibroIndex scores in predicting the presence of esophageal varices in liver cirrhosis: a systematic review and meta-analysisMedicine (Baltimore)20159442e179526496312
   PubMed Web of Science ®Google Scholar
• NyblomHBjörnssonESimrénMAldenborgFAlmerSOlssonRThe AST/ALT ratio as an indicator of cirrhosis in patients with PBCLiver Int200626784084516911467
   PubMed Web of Science ®Google Scholar
• AlempijevicTKrsticMJesicRBiochemical markers for noninvasive assessment of disease stage in patients with primary biliary cirrhosisWorld J Gastroenterol200915559159419195061
   PubMed Web of Science ®Google Scholar
• FloreaniACazzagonNMartinesDCavallettoLBaldoVChemelloLPerformance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosisDig Liver Dis2011431188789221783442
   PubMedGoogle Scholar
• StasiCLeonciniLBiaginiMRAssessment of liver fibrosis in primary biliary cholangitis: comparison between indirect serum markers and fibrosis morphometryDig Liver Dis201648329830126632448
   PubMedGoogle Scholar
• OlmezSSayarSAvciogluUThe relationship between liver histology and noninvasive markers in primary biliary cirrhosisEur J Gastroenterol Hepatol201628777377627092904
   PubMed Web of Science ®Google Scholar
• MayoMJParkesJAdams-HuetBPrediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assayHepatology20084851549155718846542
   PubMed Web of Science ®Google Scholar
• XieQZhouXHuangPWeiJWangWZhengSThe performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysisPLoS One201494e9277224736610
   PubMed Web of Science ®Google Scholar
• WangHXuHWangXRed blood cell distribution width to platelet ratio is related to histologic severity of primary biliary cirrhosisMedicine (Baltimore)20169511e311426986159
   PubMed Web of Science ®Google Scholar
• WangZLiuXXuHQuLZhangDGaoPPlatelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitisMedicine (Baltimore)2018977e984329443746
   PubMed Web of Science ®Google Scholar
• SwetsJAMeasuring the accuracy of diagnostic systemsScience19882404857128512933287615
   PubMed Web of Science ®Google Scholar
• MendesLCStucchiRSViganiAGDiagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategiesHepat Med201810132229662329
   PubMed Web of Science ®Google Scholar
• SaffiotiFGurusamyKSEusebiLHTsochatzisEDavidsonBRThorburnDPharmacological interventions for primary biliary cholangitis: an attempted network meta-analysisCochrane Database Syst Rev20173CD01164828350426
   PubMed Web of Science ®Google Scholar
• GatselisNKZachouKNormanGLClinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the diseaseAutoimmunity201346747147923777462
   PubMed Web of Science ®Google Scholar
• Agmon-LevinNKopilovRSelmiCVitamin D in primary biliary cirrhosis, a plausible marker of advanced diseaseImmunol Res2015611–214114625424577
   PubMed Web of Science ®Google Scholar
• GuoGYShiYQWangLSerum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosisAliment Pharmacol Ther201542222123025982180
   PubMed Web of Science ®Google Scholar
• ParesACaballeriaLRodesJExcellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acidGastroenterology2006130371572016530513
   PubMed Web of Science ®Google Scholar
• CorpechotCAbenavoliLRabahiNBiochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosisHepatology200848387187718752324
   PubMed Web of Science ®Google Scholar
• KumagiTGuindiMFischerSEBaseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosisAm J Gastroenterol2010105102186219420502446
   PubMed Web of Science ®Google Scholar
• CorpechotCChazouilleresOPouponREarly primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcomeJ Hepatol20115561361136721703194
   PubMed Web of Science ®Google Scholar
• PapastergiouVTsochatzisEARodriguez-PeralvarezMBiochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort studyAliment Pharmacol Ther20133811–121354136424117847
   PubMed Web of Science ®Google Scholar
• LammersWJvan BuurenHRHirschfieldGMGlobal PBC Study GroupLevels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyGastroenterology2014147613381349.e5 quiz e1525160979
   PubMed Web of Science ®Google Scholar
• LammersWJHirschfieldGMCorpechotCGlobal PBC Study GroupDevelopment and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapyGastroenterology201514971804181226261009
   PubMed Web of Science ®Google Scholar
• HarmsMHLammersWJThorburnDMajor hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcomeAm J Gastroenterol2018113225426429231188
   PubMed Web of Science ®Google Scholar
• ZhangLNShiTYShiXHEarly biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort studyHepatology201358126427223408380
   PubMed Web of Science ®Google Scholar
• CarboneMMellsGFPellsGUK PBC ConsortiumSex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acidGastroenterology2013144356056923246637
   PubMed Web of Science ®Google Scholar
• KatsushimaFTakahashiASakamotoNKannoYAbeKOhiraHExpression of microRNAs in peripheral blood mono-nuclear cells from primary biliary cirrhosis patientsHepatol Res20144410E189E19723834361
   PubMed Web of Science ®Google Scholar
• UmemuraTSekiguchiTJoshitaSAssociation between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitisLiver Int201737689790527860118
   PubMed Web of Science ®Google Scholar